Aisling Capital Management LP Portfolio Holdings

Aisling Capital Management LP

  • $442 Million
  • Q3 2025

Aisling Capital Management LP has filed its 13F form on November 12, 2025 for Q3 2025 where it was disclosed a total value porftolio of $442 Million distributed in 14 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bridge Bio Pharma, Inc. with a value of $316M, Verona Pharma PLC with a value of $65.6M, Syndax Pharmaceuticals Inc with a value of $20.3M, Nuvation Bio Inc. with a value of $11M, and Monte Rosa Therapeutics, Inc. with a value of $10.9M.

Examining the 13F form we can see an increase of $82.4M in the current position value, from $360M to 442M.

Aisling Capital Management LP is based out at New York, NY

Below you can find more details about Aisling Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $442 Million
Healthcare: $442 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$9.84B
$316 Million 71.54% of portfolio
6,089,611
Q3 2025 Added 0.35%
$6.52B
$65.6 Million 14.85% of portfolio
615,352
Q1 2025 Reduced 44.83%
$940M
$20.3 Million 4.58% of portfolio
1,316,806
Q2 2025 Added 28.47%
$1.06B
$11 Million 2.48% of portfolio
2,960,659
Q3 2025 Added 16.52%
$671M
$10.9 Million 2.47% of portfolio
1,472,331
Q2 2021 New
$363M
$10.2 Million 2.31% of portfolio
1,198,418
Q1 2025 Added 24.25%
$37.5M
$4.14 Million 0.94% of portfolio
2,048,757
Q2 2025 Added 156.49%
$1.95B
$2.88 Million 0.65% of portfolio
77,031
Q3 2025 New
$168M
$825,000 0.19% of portfolio
434,455
Q4 2022 Reduced 31.52%
On Kure Therapeutics, Inc. (Okur)
-
$0 0.0% of portfolio
-
Q4 2024 New
Marker Therapeutics, Inc. (Mrkr)
-
$0 0.0% of portfolio
-
Q4 2024 Added 3.53%
Calci Medica, Inc. (Calc)
-
$0 0.0% of portfolio
-
Q1 2024 New
Bicara Therapeutics Inc. (Bcax)
-
$0 0.0% of portfolio
-
Q3 2024 New
Bridge Bio Oncology Therapeutics (Bbot)
-
$0 0.0% of portfolio
-
Q3 2025 New

Summary

  • Portfolio
  • No. of Stocks 14
  • Current Value $442 Million
  • Prior Value $360 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 12, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 2 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Aisling Capital Management LP Portfolio

Follow Aisling Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aisling Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Aisling Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email